Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection dosing follows a carefully structured titration schedule designed to minimize side effects while maximizing weight loss outcomes. Most patients begin at 0.25 mg weekly and increase in small increments over 4–6 weeks, reaching therapeutic doses between 1.0–2.4 mg per week. PlexusDx compounds semaglutide from licensed 503A pharmacies and personalizes your protocol based on your metabolic profile, genetic markers, and clinical response—without charging more as your dose increases.
Understanding Semaglutide Injection Starting Doses
Semaglutide injection therapy begins at the lowest effective dose to allow your body to adapt to the medication's effects on appetite and blood sugar regulation. The standard starting dose is 0.25 mg once weekly, delivered as a subcutaneous injection into your abdomen, thigh, or upper arm. This low initial dose establishes tolerance and helps your healthcare provider monitor how your body responds before advancing to higher doses.
Starting low is not a weakness of the protocol—it is evidence-based safety design. Clinical trials supporting semaglutide's approval for weight loss showed that gradual dose escalation reduces nausea, vomiting, and gastrointestinal discomfort compared to rapid dose increases. Your body's GLP-1 receptors require time to upregulate and stabilize, which improves long-term medication adherence and sustained weight reduction.
How Semaglutide Injection Doses Increase Over Time
Your semaglutide injection dose typically increases by 0.25 mg weekly during the first month, stepping up from 0.25 mg to 0.5 mg to 0.75 mg to 1.0 mg in successive weeks. After reaching 1.0 mg, most patients increase by 0.25 mg every 4 weeks until reaching a maintenance dose between 1.0–2.4 mg per week, depending on your weight loss goals and tolerability. This stair-step approach mirrors the FDA-approved titration schedule used in landmark clinical trials.
PlexusDx personalizes your dose progression by evaluating your appetite suppression response, side effect profile, and weight loss trajectory at each step. If you experience excessive nausea or constipation, your protocol provider may pause at a lower dose or extend the interval between increases. Conversely, if you achieve excellent tolerance and inadequate weight loss at 1.0 mg, advancing to 1.5 mg or 2.0 mg may unlock stronger results specific to your metabolic physiology.
Personalized Dosing Based on Genetic Insights
PlexusDx Precision Peptide Genetic Test identifies variants in four key genes—GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—that influence your individual semaglutide response and optimal dose range. Patients carrying loss-of-function variants in the GLP1R gene, for example, may require higher semaglutide doses to achieve appetite suppression, while those with favorable GLP1R variants often respond powerfully to standard doses. Your genetic profile maps across 14 appetite and metabolism pathways, generating 150+ insights that inform whether you are a rapid responder, slow responder, or nausea-sensitive phenotype.
This precision approach eliminates the guesswork in dose selection. Instead of a one-size-fits-all protocol, PlexusDx analyzes your peptide pathway predispositions and adjusts your starting dose and escalation timeline accordingly. A patient with genetic markers suggesting GLP-1 hypersensitivity might begin at 0.125 mg and increase every 2 weeks, while a genetically predicted slow responder might advance more quickly. The Precision Peptide Genetic Test adds $99 after your first month of treatment and directly informs all subsequent dosing decisions.
Why Your Semaglutide Injection Price Never Changes with Dose
PlexusDx pricing for compounded semaglutide injection starts at $149 per month flat, regardless of whether you inject 0.25 mg or 2.4 mg weekly. This transparent pricing structure removes the financial barrier many patients face when doses must increase for adequate weight loss: your dose may need to go up, but your price will not. You pay one consistent monthly rate whether you are in month one at 0.5 mg or month six at 2.0 mg, with no hidden dose-level surcharges or tiered pricing schemes.
This flat-price model aligns PlexusDx with patient outcomes rather than medication quantity. You can titrate your dose confidently knowing that optimizing your weight loss response carries zero additional cost. Compounded semaglutide is HSA and FSA eligible, and PlexusDx serves all 50 states without requiring insurance or a membership fee. Your only price consideration is your commitment tier—whether you choose month-to-month flexibility, 3-month, or 6-month continuity—not the dose inside each monthly injection.
Monitoring Semaglutide Response and Adjusting Your Dose
Optimal semaglutide dosing requires regular check-ins with your PlexusDx-affiliated healthcare provider to assess weight loss, side effect burden, and metabolic markers like fasting glucose and HbA1c. Most patients schedule virtual visits at 2 weeks, 4 weeks, and then monthly to evaluate whether their current dose is generating target weight loss (typically 1–2 pounds per week) and tolerable side effects. If weight loss plateaus or side effects become limiting, your provider adjusts your dose or considers alternative compounded therapies like tirzepatide or the GLP-Squared dual-compound protocol.
PlexusDx integrates genetic insights, clinical labs, and your reported symptoms into a unified dosing framework. If your Precision Peptide Genetic Test reveals that you carry an FTO rs9939609 variant associated with higher baseline appetite set-point, your provider may recommend advancing to a higher maintenance dose sooner than standard protocols. Conversely, if genetic and clinical data suggest you are an optimal responder at 1.5 mg with excellent weight loss and minimal side effects, you may not need to increase further. This data-driven approach maximizes your long-term adherence and weight loss durability.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide injection for weight loss?
Most patients begin with 0.25 mg once weekly via subcutaneous injection, then increase by 0.25 mg weekly over 4 weeks, reaching 1.0 mg by week four. Further increases occur every 4 weeks up to a maintenance dose of 1.0–2.4 mg weekly, depending on your individual response and tolerability. PlexusDx personalizes your starting dose and escalation schedule based on genetic testing and clinical assessment.
How quickly should semaglutide doses increase for best weight loss results?
Clinical evidence supports a gradual 0.25 mg weekly or bi-weekly escalation to maximize tolerance and adherence. Rapid dose jumps increase nausea and gastrointestinal side effects without improving long-term weight loss outcomes. PlexusDx may adjust your escalation pace based on your genetic profile and symptom tolerance—some patients advance faster, others slower—but the evidence-based principle remains steady, personalized titration.
Will my PlexusDx semaglutide injection price increase if I need a higher dose?
No. PlexusDx semaglutide injection is priced at $149 per month flat, with no increases as your dose escalates from 0.25 mg to 2.4 mg or beyond. Your dose may need to go up—your price will not. The only pricing variation is your commitment tier (month-to-month, 3-month, or 6-month continuity), not the dose strength.
Can the Precision Peptide Genetic Test predict my optimal semaglutide dose?
Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes and maps 14 appetite pathways and 150+ insights that predict whether you are a rapid responder, slow responder, or nausea-sensitive to GLP-1 therapy. These genetic data inform your starting dose and escalation timeline, improving your personalized protocol. The test costs $99 after your first month of treatment.
What if semaglutide injections cause severe nausea—can my dose stay lower?
Yes. If you experience intolerable nausea or other side effects, your PlexusDx provider can maintain you at a lower, well-tolerated dose and monitor for weight loss progress. Some patients achieve excellent results at 0.75 mg or 1.0 mg weekly, while others benefit from switching to oral semaglutide, tirzepatide injection, or the GLP-Squared dual-compound protocol. Your dose is flexible and patient-centered, not rigid.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Your Journey with Tirzepatide: Understanding How Long It Takes to Feel Its Effects
Does GLP-1 Treatment Help Menopause Weight Gain? The Complete Treatment Guide